28-Sep-16 AIA Korea and SK Holdings have announced an MOU to develop Korea’s leading customer centric integrated digital health and wellness ecosystem. The companies aim to help motivate customers change and adopt a healthier lifestyle to reduce major chronic illnesses stemming from smoking, drinking, poor diet and lack of physical exercise. [image: Business Korea]

26-Sep-16 The Hong Kong Eye Hospital will hire four additional staff members for its eye cornea donation team in the hopes of boosting transplant cases by 25%. The public hospital, which runs the city’s only eye bank, currently has a 15-member team responsible for coordinating cornea donations for some 400 eye patients. [image: South China Morning Post]

26-Sep-16 Small specialised hospitals in India are planning to collaborate to expand services across the country by pooling medical expertise for maximum efficiency. “We have strong investment backing... We have planned expansion to increase to 1,000-bed facilities, from the current 108-bed hospital in Bangalore,” said Dr Anil Mehta, MD of Bangalore-based Nandana Healthcare. [image: Medical Dialogues]

23-Sep-16 Merck’s immunotherapy cancer drug Keytruda is finding its way into China as the first imported drug approved for use under a pilot program on the resort island of Hainan intended to boost medical tourism. The zone in Boao is likely to attract patients who would otherwise travel to Hong Kong or Macau for drugs yet to be approved in China. [image: Anthony Wallace / AFP / Getty Images]

21-Sep-16 SK has signed an MOU with Korea University on the development of the 'Aibril' Infectious Disease AI Diagnosis Service, based on Watson. This will be a world first, as up to now AI-based medical services have been mainly limited to diagnosing cancers. No-one has yet provided AI medical services for infectious diseases such as Middle East Respiratory Syndrome and Cholera. [image: Business Korea]